Melanie J. Wells appointed CEO of ADLM to lead strategic growth

The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) announced that its board of directors has appointed Melanie J. Wells, MPH, CAE as CEO effective January 30, 2026.

 

Prior to joining ADLM, Wells served for 2 years as CEO of the American College of Medical Genetics and Genomics (ACMG), and the ACMG Foundation for Genetic and Genomic Medicine (ACMGF).  ACMG is an organization with more than 3,000 members and an operational budget of $10.2 million. ACMGF advances the field of genetics and genomics by providing philanthropic funding to support the strategic initiatives of ACMG. She also previously held roles as Chief Operations Officer and Director of Administration at ACMG and ACMGF. Among her many accomplishments during her time there, she reduced organizational expenses by 80% within 1 calendar year and expanded the organization’s journal portfolio, resulting in a 40% increase in international reach and readership.

 

As CEO of ADLM, Wells will lead the association as it implements a new strategic plan that debuted in 2024. The five goals of the new plan include promoting excellence in scientific practice and knowledge within the fields of diagnostics and laboratory medicine; driving and influencing the use of data science in laboratory medicine; increasing recognition of the impact of laboratory medicine and empowering our members to advance healthcare; strengthening regulatory and legislative advocacy to ensure a favorable environment for advancing health for all through laboratory medicine; and ensuring organizational sustainability and financial security.